On December 11, the sterile mouse of Jiangsu Jicui Yaokang Biotechnology Co., Ltd. (hereinafter referred to as "Jicui Yaokang") stood out from more than 100 declared products, won the best innovative product award of 2020 Nanjing international life and Health Technology Conference and Expo, and was released at the innovative product press conference of the conference.
Dr. SD Shan Kai of the sterile Animal Department of jijiyaokang gave a report entitled "sterile animals - the latest research tool for human symbiotic microorganisms" at the innovative product press conference. Xu Guoping, director of the Economic Development Bureau of the Management Committee of Jiangbei new area, Liu Linlin, executive general manager of CICC capital and other relevant government and enterprise leaders came to the scene to witness the product release.
Dr. SD Shan Kai, aseptic Animal Department, Jiangsu Jicui Yaokang Biotechnology Co., Ltd
Jijiyaokang sterile mice won the best innovative product award of 2020 Nanjing international life and Health Technology Conference and Expo
The relationship between human symbiotic microorganisms and diseases has been fully confirmed in recent years. The treatment strategy targeting microbiome has become the most potential R & D direction in the field of biomedicine, and related industries have also become the latest and strongest growth point. Sterile mice can be called a "zero background" scientific research platform in the field of medical microbiology. On the premise of excluding the inherent microbial interference of mice, researchers can efficiently screen functional strains or flora that meet the research purpose, evaluate the safety and effectiveness of fecal bacteria transplantation, and construct animal models of human microbiome related diseases As a carrier of human flora, screening various drugs and treatment schemes targeting microorganisms. At present, sterile mice are gradually applied to the research of intestinal microecology, tumor immunity, metabolic diseases and so on.
Jijiyaokang first realized the industrialized production, sales and experimental services of sterile mice in the province, matched more than 14000 kinds of gene editing mice, and derived the world's largest sterile animal resource bank.
We believe that sterile mice and their huge derivative models will greatly shorten the R & D cycle of pharmaceutical products related to intestinal microorganisms and help build a healthy human life.